Administration on Intellectual and Developmental Disabilities (AIDD); Notice of Meeting via Conference Call, 2997-2998 [2013-00661]

Download as PDF 2997 Federal Register / Vol. 78, No. 10 / Tuesday, January 15, 2013 / Notices 69, Atlanta, Georgia 30333, phone: (404)498–6876, email: CPSTF@cdc.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES Purpose: The purpose of the meeting is for the Task Force to consider the findings of systematic reviews and issue findings and recommendations to help inform decision making about policy, practice, and research in a wide range of U.S. settings. Matters to be discussed: Matters to be discussed: promoting health equity, improving oral health, cancer prevention and control—preventing skin cancer, cardiovascular disease prevention and control, reducing tobacco use and secondhand smoke exposure, and diabetes prevention and control. Meeting Accessibility: This meeting is open to the public, limited only by space availability. Administration for Community Living SUPPLEMENTARY INFORMATION: Dated: January 8, 2013. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2013–00666 Filed 1–14–13; 8:45 am] BILLING CODE 4163–18–P Agency Information Collection Activities; Submission for OMB Review; Comment Request: University Centers for Excellence in Developmental Disabilities Education, Research, and Service—Annual Report Administration for Community Living, HHS. ACTION: Notice. AGENCY: The Administration on Intellectual and Developmental Disabilities (AIDD), Administration for Community Living (ACL) is announcing an opportunity to comment on the proposed collection of information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice collects comments on the information collection requirements relating to the continuation of an existing collection for University Centers for Excellence in SUMMARY: Developmental Disabilities Education, Research, and Service. DATES: Submit written comments on the collection of information by March 18, 2013. To attain the revised set of the data collection tool and to submit written comments on the collection of information by email to Suad.jama@acl.hhs.gov. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Suad Jama, 202.690.6059. Section 104 (42 U.S.C. 15004) of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (DD Act of 2000) directs the Secretary of Health and Human Services to develop and implement a system of program accountability to monitor the grantees funded under the DD Act of 2000. The program accountability system shall include the National Network of University Centers for Excellence in Developmental Disabilities Education, Research, and Service (UCEDDs) authorized under Part D of the DD Act of 2000. In addition to the accountability system, Section 154 (e) (42 U.S.C. 15064) of the DD Act of 2000 includes requirements for a UCEDD Annual Report. ACL estimates the burden of this collection of information as follows: SUPPLEMENTARY INFORMATION: ANNUAL BURDEN ESTIMATES Instrument Number of respondents Nuumber of responses per respondent Average burden hours per response Total burden hours UCEDD Annual Report .................................................................................... 67 1 1,412 94,604 Estimated Total Annual Burden Hours: 94,604. Dated: January 9, 2013. Kathy Greenlee, Administrator. [FR Doc. 2013–00657 Filed 1–14–13; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living srobinson on DSK4SPTVN1PROD with Administration on Intellectual and Developmental Disabilities (AIDD); Notice of Meeting via Conference Call President’s Committee for People with Intellectual Disabilities (PCPID), HHS. ACTION: Notice of Meeting via Conference Call. AGENCY: VerDate Mar<15>2010 17:00 Jan 14, 2013 Jkt 229001 Wednesday, February 27, 2013, from 1:30 p.m. to 3:00 p.m. EST. This meeting to be held via audio conference call, is open to the public. Details for accessing the full Committee Conference Call, for the public, are cited below: Toll Free Dial-In Number: 800–988– 9688. Pass Code: 2847971. Individuals whose full participation in the conference call will require reasonable accommodations (e.g., sign language interpreting services, assistive listening devices, materials in alternative format such as large print or Braille) should notify Madjid Karimi, PCPID Program Analyst, via email at MJ.Karimie@acl.hhs.gov, or via telephone at 202–619–0634, no later than Wednesday, February 20, 2013. PCPID will attempt to meet requests for accommodations made after that date, DATES: PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 but cannot guarantee ability to grant requests received after this deadline. Agenda: Committee members will: (a) Finalize the submission process of the 2012 Report to the President; and (b) discuss plans for developing the PCPID 2013 Report to the President. Additional Information: For further information, please contact Madjid Karimi, Program Analyst, President’s Committee for People with Intellectual Disabilities, 200 Independence Avenue, SW., Room 637D, Washington, DC 20201. Telephone: 202–619–0634. Fax: 202–260–3053. Email: MJ.Karimie@acl.hhs.gov. PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services, through the Administration on Intellectual and Developmental Disabilities, on a broad range of topics relating to programs, SUPPLEMENTARY INFORMATION: E:\FR\FM\15JAN1.SGM 15JAN1 2998 Federal Register / Vol. 78, No. 10 / Tuesday, January 15, 2013 / Notices services and supports for persons with intellectual disabilities. The PCPID Executive Order stipulates that the Committee shall: (1) Provide such advice concerning intellectual disabilities as the President or the Secretary of Health and Human Services may request; and (2) provide advice to the President concerning the following for people with intellectual disabilities: (A) Expansion of educational opportunities; (B) promotion of homeownership; (C) assurance of workplace integration; (D) improvement of transportation options; (E) expansion of full access to community living; and (F) increasing access to assistive and universally designed technologies. Dated: January 9, 2013. Kathy Greenlee, Administrator. [FR Doc. 2013–00661 Filed 1–14–13; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2004–N–0451] Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 030 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing a publication containing modifications the Agency is making to the list of standards FDA recognizes for use in premarket reviews (FDA recognized consensus standards). This publication, entitled ‘‘Modifications to the List of Recognized Standards, Recognition List Number: 030’’ (Recognition List Number: 030), will assist manufacturers who elect to declare conformity with consensus standards to meet certain requirements for medical devices. DATES: Submit written or electronic comments concerning this document at any time. See section VII of this document for the effective date of the recognition of standards announced in this document. ADDRESSES: Submit written requests for single copies of ‘‘Modifications to the List of Recognized Standards, Recognition List Number: 030’’ to the Division of Small Manufacturers, International and Consumer Assistance, Center for Devices and Radiological srobinson on DSK4SPTVN1PROD with SUMMARY: VerDate Mar<15>2010 17:00 Jan 14, 2013 Jkt 229001 Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Silver Spring, MD 20993. Send two selfaddressed adhesive labels to assist that office in processing your requests, or fax your request to 301–847–8149. Submit written comments concerning this document, or recommendations for additional standards for recognition, to the contact person (see FOR FURTHER INFORMATION CONTACT). Submit electronic comments by email: standards@cdrh.fda.gov. This document may also be accessed on FDA’s Internet site at http://www.fda.gov/ MedicalDevices/ DeviceRegulationandGuidance/ Standards/ucm123792.htm. See section VI of this document for electronic access to the searchable database for the current list of FDA recognized consensus standards, including Recognition List Number: 030 modifications and other standards related information. FOR FURTHER INFORMATION CONTACT: Scott A. Colburn, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 3632, Silver Spring, MD 20993, 301–796–6287. I. Background Section 204 of the Food and Drug Administration Modernization Act of 1997 (FDAMA) (Pub. L. 105–115) amended section 514 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360d). Amended section 514 allows FDA to recognize consensus standards developed by international and national organizations for use in satisfying portions of device premarket review submissions or other requirements. In a notice published in the Federal Register of February 25, 1998 (63 FR 9561), FDA announced the availability of a guidance entitled ‘‘Recognition and Use of Consensus Standards.’’ The notice described how FDA would implement its standard recognition program and provided the initial list of recognized standards. Modifications to the initial list of recognized standards, as published in the Federal Register, are identified in table 1 of this document. TABLE 1—PREVIOUS PUBLICATIONS OF STANDARD RECOGNITION LISTS February 25, 1998 (63 FR 9561) October 16, 1998 (63 FR 55617) July 12, 1999 (64 FR 37546) November 15, 2000 (65 FR 69022) May 7, 2001 (66 FR 23032) January 14, 2002 (67 FR 1774) October 2, 2002 (67 FR 61893) PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 TABLE 1—PREVIOUS PUBLICATIONS OF STANDARD RECOGNITION LISTS— Continued April 28, 2003 (68 FR 22391) March 8, 2004 (69 FR 10712) June 18, 2004 (69 FR 34176) October 4, 2004 (69 FR 59240) May 27, 2005 (70 FR 30756) November 8, 2005 (70 FR 67713) March 31, 2006 (71 FR 16313) June 23, 2006 (71 FR 36121) November 3, 2006 (71 FR 64718). May 21, 2007 (72 FR 28500). September 12, 2007 (72 FR 52142). December 19, 2007 (72 FR 71924). September 9, 2008 (73 FR 52358). March 18, 2009 (74 FR 11586). September 8, 2009 (74 FR 46203). May 5, 2010 (75 FR 24711). June 10, 2010 (75 FR 32943). October 4, 2010 (75 FR 61148). March 14, 2011 (76 FR 13631). August 2, 2011 (76 FR 46300). March 16, 2012 (77 FR 15765). August 20, 2012 (77 FR 50114). These notices describe the addition, withdrawal, and revision of certain standards recognized by FDA. The Agency maintains ‘‘hypertext markup language (HTML)’’ and ‘‘portable document format (PDF)’’ versions of the list of ‘‘FDA Recognized Consensus Standards.’’ Both versions are publicly accessible at the Agency’s Internet site. See section VI of this document for electronic access information. Interested persons should review the supplementary information sheet for the standard to understand fully the extent to which FDA recognizes the standard. II. Modifications to the List of Recognized Standards, Recognition List Number: 030 FDA is announcing the addition, withdrawal, correction, and revision of certain consensus standards the Agency will recognize for use in satisfying premarket reviews and other requirements for devices. FDA will incorporate these modifications in the list of FDA Recognized Consensus Standards in the Agency’s searchable database. FDA will use the term ‘‘Recognition List Number: 030’’ to identify these current modifications. In table 2 of this document, FDA describes the following modifications: (1) The withdrawal of standards and their replacement by others; (2) the correction of errors made by FDA in listing previously recognized standards; and (3) the changes to the supplementary information sheets of recognized standards that describe revisions to the applicability of the standards. In section III of this document, FDA lists modifications the Agency is making E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 78, Number 10 (Tuesday, January 15, 2013)]
[Notices]
[Pages 2997-2998]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00661]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Community Living


Administration on Intellectual and Developmental Disabilities 
(AIDD); Notice of Meeting via Conference Call

AGENCY: President's Committee for People with Intellectual Disabilities 
(PCPID), HHS.

ACTION: Notice of Meeting via Conference Call.

-----------------------------------------------------------------------

DATES: Wednesday, February 27, 2013, from 1:30 p.m. to 3:00 p.m. EST. 
This meeting to be held via audio conference call, is open to the 
public.
    Details for accessing the full Committee Conference Call, for the 
public, are cited below:
    Toll Free Dial-In Number: 800-988-9688.
    Pass Code: 2847971.
    Individuals whose full participation in the conference call will 
require reasonable accommodations (e.g., sign language interpreting 
services, assistive listening devices, materials in alternative format 
such as large print or Braille) should notify Madjid Karimi, PCPID 
Program Analyst, via email at MJ.Karimie@acl.hhs.gov, or via telephone 
at 202-619-0634, no later than Wednesday, February 20, 2013. PCPID will 
attempt to meet requests for accommodations made after that date, but 
cannot guarantee ability to grant requests received after this 
deadline.
    Agenda: Committee members will: (a) Finalize the submission process 
of the 2012 Report to the President; and (b) discuss plans for 
developing the PCPID 2013 Report to the President.
    Additional Information: For further information, please contact 
Madjid Karimi, Program Analyst, President's Committee for People with 
Intellectual Disabilities, 200 Independence Avenue, SW., Room 637D, 
Washington, DC 20201. Telephone: 202-619-0634. Fax: 202-260-3053. 
Email: MJ.Karimie@acl.hhs.gov.

SUPPLEMENTARY INFORMATION: PCPID acts in an advisory capacity to the 
President and the Secretary of Health and Human Services, through the 
Administration on Intellectual and Developmental Disabilities, on a 
broad range of topics relating to programs,

[[Page 2998]]

services and supports for persons with intellectual disabilities. The 
PCPID Executive Order stipulates that the Committee shall: (1) Provide 
such advice concerning intellectual disabilities as the President or 
the Secretary of Health and Human Services may request; and (2) provide 
advice to the President concerning the following for people with 
intellectual disabilities: (A) Expansion of educational opportunities; 
(B) promotion of homeownership; (C) assurance of workplace integration; 
(D) improvement of transportation options; (E) expansion of full access 
to community living; and (F) increasing access to assistive and 
universally designed technologies.

    Dated: January 9, 2013.
Kathy Greenlee,
Administrator.
[FR Doc. 2013-00661 Filed 1-14-13; 8:45 am]
BILLING CODE 4154-01-P